These medications help decrease appetite, reduce cravings, improve insulin sensitivity, and slow gastric emptying so you feel fuller longersupporting steady, sustainable weight loss and improved overall metabolic health
Tirzepatide GLP-1 medications have changed the landscape of metabolic medicine
Semaglutide is FDA-approved for Type 2 diabetes management
Current Clinical Trial Status (Updated May 2026) The TRIUMPH and TRANSCEND-T2D programs are Eli Lilly's parallel Phase 3 readouts for retatrutide
Deletion of hypoxia-inducible factor-1 in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation
This hypothesis has been bouncing around my head for a few years now, related to Alnylam Pharmaceuticals newest drug, Amvuttra, indicated for hATTR-PN and ATTR-CM